RecruitingNCT07679321
Anxiety, depression, asthma medication response and flare-up risk
About this title
Read the official source — NCT07679321Observational studyAges 14+China
Understand this study
Who could participate?
Listed age limits: from 14 years.
- Listed locations
- ChangshaSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 1, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 256
- Sponsor
- Xiangya Hospital of Central South University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Other
- Locations
- China
- Age range
- Over 14 Years
- Official registry ID
- NCT07679321
- Official title
Show the full official title
The Impact of Anxiety/Depression on the Efficacy of Asthma Control Drugs and the Construction of a Predictive Model for the Risk of Acute Asthma Attacks
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Changsha
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Xiangya Hospital of Central South University, a university.
Who can participate?
Listed age limits: from 14 years.
Is this study still recruiting?
The registry lists this study as recruiting.
